Home
Conditions
Myeloproliferative Neoplasm

Clinical trial condition

Myeloproliferative Neoplasm

Explore clinical trials studying Myeloproliferative Neoplasm. Study availability and eligibility vary by location and protocol.

112 public trials 37 recruiting studies

Refine in advanced search Browse all conditions

Myeloproliferative Neoplasm trial results

Recruiting

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

NCT06059391

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +34 more
Locations: City of Hope Medical Center Duarte, California, United States

Northside Hospital Atlanta, Georgia, United States

DFCI/BWH Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details

Recruiting

An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms

NCT05123365

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +16 more
Locations: University of California, Irvine Irvine, California, United States

Chao Family Comprehensive Cancer Center, University of California, Irvine Orange, California, United States

View Trial Details

Recruiting

Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)

NCT04942080

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +11 more
Locations: CHU Angers Angers, France

Chu Bordeaux Bordeaux, France

Chu Brest Brest, France

Ch Cholet Cholet, France

View Trial Details

Recruiting

Identification of Factors Associated With Treatment Response in Patients With Polycythemia Vera, Essential Thrombocythemia, and Pre-myelofibrosis.

NCT05440838

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Chu Angers Angers, France

Chu Brest Brest, France

Chu Nantes Nantes, France

Chu Poitiers Poitiers, France

View Trial Details

Recruiting

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

NCT03630991

Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blast Crisis, +35 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

NCT05745285

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hematologic Neoplasms, +15 more
Locations: Sylvester Comprehensive Cancer Center Miami, Florida, United States

University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

Mays Cancer Center at UT Health San Antonio San Antonio, Texas, United States

View Trial Details

Recruiting

Prognostic Value of NETosis Markers for Thrombosis During Myeloproliferative Neoplasms (AVATARE)

NCT07119970

Conditions: Bone Marrow Diseases, Cardiovascular Diseases, Embolism and Thrombosis, +6 more
Locations: CHU d'Angers, Service des maladies du Sang Angers, France

CH de la Côte Basque, Service Hématologie Bayonne, France

CHU de Bordeaux, Service Hématologie Biologique Bordeaux, France

CHU de Bordeaux, Service Hématologie Clinique et Thérapie Cellulaire Bordeaux, France

View all 15 locations

View Trial Details

Recruiting

Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes

NCT06361641

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +14 more
Locations: GOUBAND Agathe Angers, Maine et Loire, France

BESCOND Charles Cholet, Maine et Loire, France

TRUCHAN-GRACZYK Malgorzata Saumur, Maine et Loire, France

View Trial Details

Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT03452774

Conditions: Adenocarcinoma, Adnexal Diseases, Astrocytoma, +144 more
Locations: Massive Bio SYNERGY-AI site Birmingham, Alabama, United States

Massive Bio SYNERGY-AI site Mobile, Alabama, United States

Massive Bio SYNERGY-AI site Scottsdale, Arizona, United States

Massive Bio SYNERGY-AI site Little Rock, Arkansas, United States

View all 68 locations

View Trial Details

Recruiting

Impact of Epigenetic Age on Clinic-biological Presentation and Prognosis in Myeloproliferative Neoplasms Epigenetic Age in Myeloproliferative Neoplasms (EpiC)

NCT06022328

Conditions: Bone Marrow Diseases, Cardiovascular Diseases, Embolism and Thrombosis, +10 more
Locations: CHU de Bordeaux, service Hématologie Biologique Bordeaux, France

View Trial Details

Myeloproliferative Neoplasm

Myeloproliferative Neoplasm trial results

Related conditions